Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: An important diagnostic distinction;Erythema multiforme versus Stevens-Johnson-syndroom en toxische epidermale necrolyse; belangrijk diagnostisch onderscheid

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 43, 2003, Pages 2089-2094

  Rabelink, N M ^a   Brakman, M ^a   Maartense, E ^a   Bril, H ^a   Bakker Wensveen, C A H Bearda ^b   Bavinck, J N Bouwes ^b  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMOXICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIMALARIAL AGENT; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN; MEFLOQUINE; PREDNISONE; PROGUANIL; SULFONAMIDE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY REACTION; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOGENESIS; SCHOOL CHILD; SKIN NECROSIS; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY; TOXIC EPIDERMAL NECROLYSIS;

CHILD; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; FATAL OUTCOME; FEMALE; HUMANS; IATROGENIC DISEASE; MIDDLE AGED; PROGNOSIS; STEVENS-JOHNSON SYNDROME;

EID: 0142198447     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
2. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994;102:28S-30S.
3. Roujeau JC, Kelly JP, Nuldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
4. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997;24:726-9.
5. Smoot 3rd EC. Treatment issues in the care of patients with toxic epidermal necrolysis. Burns 1999;25:439-42.
6. Meer JB van der. Stevens-Johnson-syndroom en toxische epidermale necrolyse: therapiebeleid bij deze levensbedreigende ziekten. Ned Tijdschr Geneeskd 1996;140:1538-43.
7. Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clin 2002;18:485-95.
8. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000;136:323-7.
9. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987;123:1160-5.
10. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991;127:839-42.
11. Meer JB van der, Schuttelaar ML, Toth GG, Kardaun SH, Beerthuizen G, Jong MC de, et al. Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam. Clin Exp Dermatol 2001;26:654-6.
12. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3.
13. Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003;139:26-32.
14. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003;139:33-6.
15. Chaidemenos GC, Chrysomallis F, Sombolos K, Mourellou O, Ioannides D, Papakonstantinou M. Plasmapheresis in toxic epidermal necrolysis. Int J Dermatol 1997;36:218-21.
16. Jarrett P, Rademaker M, Havill J, Pullon H. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor. Clin Exp Dermatol 1997;22:146-7.